Asia Pacific Blood Screening Market - Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025
Asia Pacific Blood Screening Market is expected to reach with healthy CAGR of 10.5% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
Market Segmentation
By Products & Services (Reagents & Kits, Instruments, Software & Services), Technology (Enzyme-Linked Immunosorbent Assay, Rapid Tests, Next-Generation Sequencing, Nucleic Acid Test, Western Blot Assay, Others), Disease Type (Oncology, Diabetes Mellitus, Cold & Flu, Cholesterol, Infectious Diseases, Respiratory Diseases, HIV/AIDS, Others), End User (Diagnostic Centers, Blood Bank, Hospitals, Clinics, Ambulatory Surgical Centers), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa)
Major growing sectors under the market segmentation are as follows:
Market Segmentation
By Products & Services (Reagents & Kits, Instruments, Software & Services), Technology (Enzyme-Linked Immunosorbent Assay, Rapid Tests, Next-Generation Sequencing, Nucleic Acid Test, Western Blot Assay, Others), Disease Type (Oncology, Diabetes Mellitus, Cold & Flu, Cholesterol, Infectious Diseases, Respiratory Diseases, HIV/AIDS, Others), End User (Diagnostic Centers, Blood Bank, Hospitals, Clinics, Ambulatory Surgical Centers), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa)
Major growing sectors under the market segmentation are as follows:
- In products & services, reagents are dominating this market as reagents are majorly used in laboratory, company and other places to perform experiment and also to find or detect the diseases related to human health.
- In technology, enzyme-linked immunosorbent assay (ELISA) is dominating this market as it is more used with accurate result and less costly in the market. It is a versatile tool for physicians, laboratories, and medical professionals all over the world.
- In disease type, oncology is dominating this market as increasing population is detecting more with cancer cases due to exposure to UV lights in today’s world. The Blood screening method is found to be more useful for detecting cancer.
- In end user, diagnostic centers is dominating this market as people mostly prefer diagnostics centers and doctors also suggest patients to visit diagnostics center for detection of diseases.
- Enzo Biochem Inc.
- Meridian Bioscience, Inc.
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- BD
- bioMérieux SA
- Beckman Coulter, Inc.
- Abbott
- F. Hoffmann-La Roche Ltd
- Cepheid
- Grifols
- Seimens AG
- Ortho Clinical Diagnostics
- Immucor, Inc.
- Hologic Inc.
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC BLOOD SCREENING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 THE CATEGORY VS TIME GRID
2.9 THE CATEGORY VS TIME GRID
2.10 DBMR MARKET CHALLENGE MATRIX
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 RISE IN THE DEMAND OF BLOOD DONATIONS AND BLOOD DONORS
3.1.2 RISING PREVALENCE IN NUMBER OF DISEASES
3.1.3 RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS
3.2 RESTRAINTS
3.2.1 LACK OF USING NAT TECHNLOGY IN EMERGING COUNTRIES
3.2.2 HIGH COST OF TECHNOLOGY AND INSTRUMENTS
3.2.3 EMERGING ALTERNATIVE TECHNOLOGIES
3.3 OPPORTUNITIES
3.3.1 INCREASING MICROBIOLOGY SCREENING & MULTIPLEXING
3.4 CHALLENGES
3.4.1 REDUCTION IN PRICE FOR TECHNOLOGY AND INSTRUMENT
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES
6.1 OVERVIEW
6.2 REAGENTS & KITS
6.2.1 ELISA REAGENTS & KITS
6.2.1.1 IMMUNOSORBENTS
6.2.1.2 CONJUGATES
6.2.1.3 SUBSTRATES
6.2.1.4 CONTROLS
6.2.1.5 SAMPLE DILUENTS AND WASH SOLUTIONS
6.2.2 NAT REAGENTS & KITS
6.2.2.1 PROBES AND PRIMERS
6.2.2.2 ENZYMES AND POLYMERASES
6.2.2.3 LABELING AND DETECTION REAGENTS
6.2.2.4 STANDARDS AND CONTROLS
6.2.2.5 BUFFERS, NUCLEOTIDES AND SOLUTIONS
6.3 INSTRUMENTS
6.3.1.1 INSTRUMENTS, PRODUCT TYPE
6.3.1.1.1 SEMI AUTOMATED
6.3.1.1.2 AUTOMATED
6.3.1.2 INSTRUMENTS, PURCHASE TYPE
6.3.1.2.1 OUTRIGHT PURCHASE
6.3.1.2.2 RENTAL
6.4 SOFTWARE & SERVICES
7 ASIA-PACIFIC BLOOD SCREENING MARKET, BY TECHNOLOGY
7.1 OVERVIEW
7.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)
7.2.1 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY PLATFORM
7.2.1.1 COLORIMETRIC IMMUNOASSAY (CI)
7.2.1.2 CHEMILUMINESCENCE IMMUNOASSAY (CLIA)
7.2.1.3 FLUORESCENCE IMMUNOASSAY (FIA)
7.2.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY GENERATIONS
7.2.2.1 FIRST-GENERATION ELISA
7.2.2.2 SECOND-GENERATION ELISA
7.2.2.3 THIRD-GENERATION ELISA
7.2.2.4 FOURTH-GENERATION ELISA
7.3 RAPID TESTS
7.4 NEXT-GENERATION SEQUENCING (NGS)
7.5 NUCLEIC ACID TEST
7.5.1 REAL-TIME POLYMERASE CHAIN REACTION (PCR)
7.5.2 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA)
7.6 WESTERN BLOT ASSAY
7.7 OTHERS
8 ASIA-PACIFIC BLOOD SCREENING MARKET, BY DISEASE TYPE
8.1 OVERVIEW
8.2 ONCOLOGY
8.3 DIABETES MELLITUS
8.4 COLD & FLU
8.5 CHOLESTEROL
8.6 INFECTIOUS DISEASES
8.7 RESPIRATORY DISEASES
8.8 HIV/AIDS
8.9 OTHERS
9 ASIA-PACIFIC BLOOD SCREENING MARKET, BY END USER
9.1 OVERVIEW
9.2 DIAGNOSTIC CENTERS
9.3 BLOOD BANK
9.4 HOSPITALS
9.5 CLINICS
9.6 AMBULATORY SURGICAL CENTERS
10 ASIA-PACIFIC BLOOD SCREENING MARKET, BY GEOGRAPHY
10.1 ASIA-PACIFIC
10.1.1 CHINA
10.1.2 JAPAN
10.1.3 SOUTH KOREA
10.1.4 INDIA
10.1.5 SINGAPORE
10.1.6 AUSTRALIA
10.1.7 THAILAND
10.1.8 MALAYSIA
10.1.9 INDONESIA
10.1.10 PHILIPPINES
10.1.11 REST OF ASIA-PACIFIC
11 ASIA-PACIFIC BLOOD SCREENING MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
12 COMPANY PROFILES
12.1 F. HOFFMANN-LA ROCHE LTD
12.1.1 COMPANY OVERVIEW
12.1.2 REVENUEANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENT
12.2 ABBOTT
12.2.1 COMPANY OVERVIEW
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHAREV ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 THERMO FISHER SCIENTIFIC INC.
12.3.1 COMPANY OVERVIEW
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHAREV ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENTS
12.4 SIEMENS AG
12.4.1 COMPANY OVERVIEW
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHAREV ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENTS
12.5 BIO-RAD LABORATORIES, INC.
12.5.1 1.3.1COMPANY OVERVIEW
12.5.2 REVENUE ANALYSIS
12.5.3 COMPANY SHAREV ANALYSIS
12.5.4 PRODUCT PORTFOLIO
12.5.5 RECENT DEVELOPMENTS
12.6 BD
12.6.1 COMPANY OVERVIEW
12.6.2 REVENUE ANALYSIS
12.6.3 PRODUCT PORTFOLIO
12.6.4 RECENT DEVELOPMENTS
12.7 BECKMAN COULTER, INC.
12.7.1 COMPANY OVERVIEW
12.7.2 GEOGRAPHICPRESENCE
12.7.3 PODUCT PORTFOLIO
12.7.4 RECENET DEVELOPEMENTS
12.8 BIOMÉRIEUX SA
12.8.1 COMPANY OVERVIEW
12.8.2 REVENUE ANALYSIS
12.8.3 PRODUCT PORTFOLIO
12.8.4 RECENT DEVELOPMENT
12.9 CEPHEID (A SUBSIDIARY OF DANAHER CORPORATION)
12.9.1 COMPANY OVERVIEW
12.9.2 GEOGRAPHIC PRESENCE
12.9.3 PRODUCT PORTFOLIO
12.9.4 RECENT DEVELOPMENT
12.10 ENZO BIOCHEM INC.
12.10.1 COMPANY OVERVIEW
12.10.2 REVENUE ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 RECENT DEVELOPMENTS
12.11 GRIFOLS INTERNATIONAL, S.A.
12.11.1 COMPANY OVERVIEW
12.11.2 REVENUE ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 RECENT DEVELOPMENTS
12.12 HOLOGIC INC.
12.12.1 COMPANY OVERVIEW
12.12.2 REVENUE ANALYSIS
12.12.3 PRODUCT PORTFOLIO
12.12.4 RECENT DEVELOPMENTS
12.13 IMMUCOR, INC.
12.13.1 COMPANY OVERVIEW
12.13.2 GEOGRAPHIC PRESENCE:
12.13.3 PRODUCT PORTFOLIO
12.13.4 RECENT DEVELOPMENTS
12.14 MERIDIAN BIOSCIENCE, INC.
12.14.1 COMPANY OVERVIEW
12.14.2 REVENUE ANALYSIS
12.14.3 PRODUCT PORTFOLIO
12.14.4 RECENT DEVELOPMENTS
12.15 ORTHO CLINICAL DIAGNOSTICS
12.15.1 COMPANY OVERVIEW
12.15.2 GEOGRAPHIC PRESENCE
12.15.3 PRODUCT PORTFOLIO
12.15.4 RECENT DEVELOPMENTS
13 RELATED REPORTS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC BLOOD SCREENING MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHIC SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 RESEARCH METHODOLOGY
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 THE CATEGORY VS TIME GRID
2.9 THE CATEGORY VS TIME GRID
2.10 DBMR MARKET CHALLENGE MATRIX
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.1.1 RISE IN THE DEMAND OF BLOOD DONATIONS AND BLOOD DONORS
3.1.2 RISING PREVALENCE IN NUMBER OF DISEASES
3.1.3 RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS
3.2 RESTRAINTS
3.2.1 LACK OF USING NAT TECHNLOGY IN EMERGING COUNTRIES
3.2.2 HIGH COST OF TECHNOLOGY AND INSTRUMENTS
3.2.3 EMERGING ALTERNATIVE TECHNOLOGIES
3.3 OPPORTUNITIES
3.3.1 INCREASING MICROBIOLOGY SCREENING & MULTIPLEXING
3.4 CHALLENGES
3.4.1 REDUCTION IN PRICE FOR TECHNOLOGY AND INSTRUMENT
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES
6.1 OVERVIEW
6.2 REAGENTS & KITS
6.2.1 ELISA REAGENTS & KITS
6.2.1.1 IMMUNOSORBENTS
6.2.1.2 CONJUGATES
6.2.1.3 SUBSTRATES
6.2.1.4 CONTROLS
6.2.1.5 SAMPLE DILUENTS AND WASH SOLUTIONS
6.2.2 NAT REAGENTS & KITS
6.2.2.1 PROBES AND PRIMERS
6.2.2.2 ENZYMES AND POLYMERASES
6.2.2.3 LABELING AND DETECTION REAGENTS
6.2.2.4 STANDARDS AND CONTROLS
6.2.2.5 BUFFERS, NUCLEOTIDES AND SOLUTIONS
6.3 INSTRUMENTS
6.3.1.1 INSTRUMENTS, PRODUCT TYPE
6.3.1.1.1 SEMI AUTOMATED
6.3.1.1.2 AUTOMATED
6.3.1.2 INSTRUMENTS, PURCHASE TYPE
6.3.1.2.1 OUTRIGHT PURCHASE
6.3.1.2.2 RENTAL
6.4 SOFTWARE & SERVICES
7 ASIA-PACIFIC BLOOD SCREENING MARKET, BY TECHNOLOGY
7.1 OVERVIEW
7.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)
7.2.1 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY PLATFORM
7.2.1.1 COLORIMETRIC IMMUNOASSAY (CI)
7.2.1.2 CHEMILUMINESCENCE IMMUNOASSAY (CLIA)
7.2.1.3 FLUORESCENCE IMMUNOASSAY (FIA)
7.2.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY GENERATIONS
7.2.2.1 FIRST-GENERATION ELISA
7.2.2.2 SECOND-GENERATION ELISA
7.2.2.3 THIRD-GENERATION ELISA
7.2.2.4 FOURTH-GENERATION ELISA
7.3 RAPID TESTS
7.4 NEXT-GENERATION SEQUENCING (NGS)
7.5 NUCLEIC ACID TEST
7.5.1 REAL-TIME POLYMERASE CHAIN REACTION (PCR)
7.5.2 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA)
7.6 WESTERN BLOT ASSAY
7.7 OTHERS
8 ASIA-PACIFIC BLOOD SCREENING MARKET, BY DISEASE TYPE
8.1 OVERVIEW
8.2 ONCOLOGY
8.3 DIABETES MELLITUS
8.4 COLD & FLU
8.5 CHOLESTEROL
8.6 INFECTIOUS DISEASES
8.7 RESPIRATORY DISEASES
8.8 HIV/AIDS
8.9 OTHERS
9 ASIA-PACIFIC BLOOD SCREENING MARKET, BY END USER
9.1 OVERVIEW
9.2 DIAGNOSTIC CENTERS
9.3 BLOOD BANK
9.4 HOSPITALS
9.5 CLINICS
9.6 AMBULATORY SURGICAL CENTERS
10 ASIA-PACIFIC BLOOD SCREENING MARKET, BY GEOGRAPHY
10.1 ASIA-PACIFIC
10.1.1 CHINA
10.1.2 JAPAN
10.1.3 SOUTH KOREA
10.1.4 INDIA
10.1.5 SINGAPORE
10.1.6 AUSTRALIA
10.1.7 THAILAND
10.1.8 MALAYSIA
10.1.9 INDONESIA
10.1.10 PHILIPPINES
10.1.11 REST OF ASIA-PACIFIC
11 ASIA-PACIFIC BLOOD SCREENING MARKET, COMPANY LANDSCAPE
11.1 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
12 COMPANY PROFILES
12.1 F. HOFFMANN-LA ROCHE LTD
12.1.1 COMPANY OVERVIEW
12.1.2 REVENUEANALYSIS
12.1.3 COMPANY SHARE ANALYSIS
12.1.4 PRODUCT PORTFOLIO
12.1.5 RECENT DEVELOPMENT
12.2 ABBOTT
12.2.1 COMPANY OVERVIEW
12.2.2 REVENUE ANALYSIS
12.2.3 COMPANY SHAREV ANALYSIS
12.2.4 PRODUCT PORTFOLIO
12.2.5 RECENT DEVELOPMENT
12.3 THERMO FISHER SCIENTIFIC INC.
12.3.1 COMPANY OVERVIEW
12.3.2 REVENUE ANALYSIS
12.3.3 COMPANY SHAREV ANALYSIS
12.3.4 PRODUCT PORTFOLIO
12.3.5 RECENT DEVELOPMENTS
12.4 SIEMENS AG
12.4.1 COMPANY OVERVIEW
12.4.2 REVENUE ANALYSIS
12.4.3 COMPANY SHAREV ANALYSIS
12.4.4 PRODUCT PORTFOLIO
12.4.5 RECENT DEVELOPMENTS
12.5 BIO-RAD LABORATORIES, INC.
12.5.1 1.3.1COMPANY OVERVIEW
12.5.2 REVENUE ANALYSIS
12.5.3 COMPANY SHAREV ANALYSIS
12.5.4 PRODUCT PORTFOLIO
12.5.5 RECENT DEVELOPMENTS
12.6 BD
12.6.1 COMPANY OVERVIEW
12.6.2 REVENUE ANALYSIS
12.6.3 PRODUCT PORTFOLIO
12.6.4 RECENT DEVELOPMENTS
12.7 BECKMAN COULTER, INC.
12.7.1 COMPANY OVERVIEW
12.7.2 GEOGRAPHICPRESENCE
12.7.3 PODUCT PORTFOLIO
12.7.4 RECENET DEVELOPEMENTS
12.8 BIOMÉRIEUX SA
12.8.1 COMPANY OVERVIEW
12.8.2 REVENUE ANALYSIS
12.8.3 PRODUCT PORTFOLIO
12.8.4 RECENT DEVELOPMENT
12.9 CEPHEID (A SUBSIDIARY OF DANAHER CORPORATION)
12.9.1 COMPANY OVERVIEW
12.9.2 GEOGRAPHIC PRESENCE
12.9.3 PRODUCT PORTFOLIO
12.9.4 RECENT DEVELOPMENT
12.10 ENZO BIOCHEM INC.
12.10.1 COMPANY OVERVIEW
12.10.2 REVENUE ANALYSIS
12.10.3 PRODUCT PORTFOLIO
12.10.4 RECENT DEVELOPMENTS
12.11 GRIFOLS INTERNATIONAL, S.A.
12.11.1 COMPANY OVERVIEW
12.11.2 REVENUE ANALYSIS
12.11.3 PRODUCT PORTFOLIO
12.11.4 RECENT DEVELOPMENTS
12.12 HOLOGIC INC.
12.12.1 COMPANY OVERVIEW
12.12.2 REVENUE ANALYSIS
12.12.3 PRODUCT PORTFOLIO
12.12.4 RECENT DEVELOPMENTS
12.13 IMMUCOR, INC.
12.13.1 COMPANY OVERVIEW
12.13.2 GEOGRAPHIC PRESENCE:
12.13.3 PRODUCT PORTFOLIO
12.13.4 RECENT DEVELOPMENTS
12.14 MERIDIAN BIOSCIENCE, INC.
12.14.1 COMPANY OVERVIEW
12.14.2 REVENUE ANALYSIS
12.14.3 PRODUCT PORTFOLIO
12.14.4 RECENT DEVELOPMENTS
12.15 ORTHO CLINICAL DIAGNOSTICS
12.15.1 COMPANY OVERVIEW
12.15.2 GEOGRAPHIC PRESENCE
12.15.3 PRODUCT PORTFOLIO
12.15.4 RECENT DEVELOPMENTS
13 RELATED REPORTS
LIST OF TABLES
Table 1 LIST OF PRICES FOR FEW DEVICES
Table 2 ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025, (USD MILLION)
Table 3 ASIA-PACIFIC REAGENTS & KITS IN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 4 ASIA-PACIFIC REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 5 ASIA-PACIFIC ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 6 ASIA-PACIFIC NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 7 ASIA-PACIFIC INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 8 ASIA-PACIFIC INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 9 ASIA-PACIFIC INSTRUMENTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 10 ASIA-PACIFIC SOFTWARE & SERVICES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 11 ASIA-PACIFIC BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 12 ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 13 ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 14 ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY REGION , 2016-2025 (USD MILLION)
Table 15 ASIA-PACIFIC RAPID TESTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 16 ASIA-PACIFIC NEXT-GENERATION SEQUENCING (NGS) IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 17 ASIA-PACIFIC NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 18 ASIA-PACIFIC NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 19 ASIA-PACIFIC WESTERN BLOT ASSAY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 20 ASIA-PACIFIC OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 21 ASIA-PACIFIC BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 22 ASIA-PACIFIC ONCOLOGY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 23 ASIA-PACIFIC DIABETES MELLITUS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 24 ASIA-PACIFIC COLD & FLU IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 25 ASIA-PACIFIC CHOLESTEROL IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 26 ASIA-PACIFIC INFECTIOUS DISEASES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 27 ASIA-PACIFIC RESPIRATORY DISEASESIN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 28 ASIA-PACIFIC HIV/AIDS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 29 ASIA-PACIFIC OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 30 ASIA-PACIFIC BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 31 ASIA-PACIFIC DIAGNOSTIC CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 32 ASIA-PACIFIC BLOOD BANK IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 33 ASIA-PACIFIC HOSPITALS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 34 ASIA-PACIFIC CLINICS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 35 ASIA-PACIFIC AMBULATORY SURGICAL CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 36 ASIA-PACIFIC HOME HEALTHCARE MARKET, BY COUTRY, 2016-2025 (USD MILLION)
Table 37 ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 38 ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 39 ASIA-PACIFIC ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 40 ASIA-PACIFIC NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 41 ASIA-PACIFIC INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 42 ASIA-PACIFIC INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 43 ASIA-PACIFIC BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 44 ASIA-PACIFIC NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 45 ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 46 ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 47 ASIA-PACIFIC BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 48 ASIA-PACIFIC BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 49 CHINA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 50 CHINA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 51 CHINA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 52 CHINA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 53 CHINA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 54 CHINA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 55 CHINA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 56 CHINA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 57 CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 58 CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 59 CHINA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 60 CHINA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 61 JAPAN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 62 JAPAN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 63 JAPAN ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 64 JAPAN NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 65 JAPAN INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 66 JAPAN INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 67 JAPAN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 68 JAPAN NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 69 JAPAN ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 70 JAPAN ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 71 JAPAN BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 72 JAPAN BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 73 SOUTH KOREA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 74 SOUTH KOREA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 75 SOUTH KOREA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 76 SOUTH KOREA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 77 SOUTH KOREA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 78 SOUTH KOREA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 79 SOUTH KOREA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 80 SOUTH KOREA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 81 SOUTH KOREA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 82 SOUTH KOREA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 83 SOUTH KOREA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 84 SOUTH KOREA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 85 INDIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 86 INDIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 87 INDIA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 88 INDIA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 89 INDIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 90 INDIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 91 INDIA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 92 INDIA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 93 INDIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 94 INDIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 95 INDIA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 96 INDIA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 97 SINGAPORE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 98 SINGAPORE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 99 SINGAPORE ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 100 SINGAPORE NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 101 SINGAPORE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 102 SINGAPORE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 103 SINGAPORE BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 104 SINGAPORE NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 105 SINGAPORE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 106 SINGAPORE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 107 SINGAPORE BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 108 SINGAPORE BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 109 AUSTRALIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 110 AUSTRALIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 111 AUSTRALIA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 112 AUSTRALIA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 113 AUSTRALIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 114 AUSTRALIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 115 AUSTRALIA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 116 AUSTRALIA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 117 AUSTRALIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 118 AUSTRALIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 119 AUSTRALIA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 120 AUSTRALIA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 121 THAILAND BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 122 THAILAND BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 123 THAILAND ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 124 THAILAND NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 125 THAILAND INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 126 THAILAND INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 127 THAILAND BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 128 THAILAND NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 129 THAILAND ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 130 THAILAND ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 131 THAILAND BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 132 THAILAND BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 133 MALAYSIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 134 MALAYSIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 135 MALAYSIA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 136 MALAYSIA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 137 MALAYSIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 138 MALAYSIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 139 MALAYSIA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 140 MALAYSIA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 141 MALAYSIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 142 MALAYSIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 143 MALAYSIA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 144 MALAYSIA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 145 INDONESIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 146 INDONESIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 147 INDONESIA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 148 INDONESIA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 149 INDONESIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 150 INDONESIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 151 INDONESIA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 152 INDONESIA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 153 INDONESIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 154 INDONESIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 155 INDONESIA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 156 INDONESIA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 157 PHILIPPINES BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 158 PHILIPPINES BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 159 PHILIPPINES ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 160 PHILIPPINES NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 161 PHILIPPINES INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 162 PHILIPPINES INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 163 PHILIPPINES BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 164 PHILIPPINES NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 165 PHILIPPINES ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 166 PHILIPPINES ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 167 PHILIPPINES BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 168 PHILIPPINES BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 169 REST OF ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 1 LIST OF PRICES FOR FEW DEVICES
Table 2 ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025, (USD MILLION)
Table 3 ASIA-PACIFIC REAGENTS & KITS IN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 4 ASIA-PACIFIC REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 5 ASIA-PACIFIC ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 6 ASIA-PACIFIC NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 7 ASIA-PACIFIC INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 8 ASIA-PACIFIC INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 9 ASIA-PACIFIC INSTRUMENTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 10 ASIA-PACIFIC SOFTWARE & SERVICES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 11 ASIA-PACIFIC BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 12 ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 13 ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 14 ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY REGION , 2016-2025 (USD MILLION)
Table 15 ASIA-PACIFIC RAPID TESTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 16 ASIA-PACIFIC NEXT-GENERATION SEQUENCING (NGS) IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 17 ASIA-PACIFIC NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 18 ASIA-PACIFIC NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 19 ASIA-PACIFIC WESTERN BLOT ASSAY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 20 ASIA-PACIFIC OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 21 ASIA-PACIFIC BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 22 ASIA-PACIFIC ONCOLOGY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 23 ASIA-PACIFIC DIABETES MELLITUS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 24 ASIA-PACIFIC COLD & FLU IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 25 ASIA-PACIFIC CHOLESTEROL IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 26 ASIA-PACIFIC INFECTIOUS DISEASES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 27 ASIA-PACIFIC RESPIRATORY DISEASESIN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 28 ASIA-PACIFIC HIV/AIDS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 29 ASIA-PACIFIC OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 30 ASIA-PACIFIC BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 31 ASIA-PACIFIC DIAGNOSTIC CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 32 ASIA-PACIFIC BLOOD BANK IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 33 ASIA-PACIFIC HOSPITALS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 34 ASIA-PACIFIC CLINICS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 35 ASIA-PACIFIC AMBULATORY SURGICAL CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION)
Table 36 ASIA-PACIFIC HOME HEALTHCARE MARKET, BY COUTRY, 2016-2025 (USD MILLION)
Table 37 ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 38 ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 39 ASIA-PACIFIC ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 40 ASIA-PACIFIC NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 41 ASIA-PACIFIC INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 42 ASIA-PACIFIC INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 43 ASIA-PACIFIC BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 44 ASIA-PACIFIC NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 45 ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 46 ASIA-PACIFIC ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 47 ASIA-PACIFIC BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 48 ASIA-PACIFIC BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 49 CHINA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 50 CHINA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 51 CHINA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 52 CHINA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 53 CHINA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 54 CHINA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 55 CHINA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 56 CHINA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 57 CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 58 CHINA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 59 CHINA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 60 CHINA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 61 JAPAN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 62 JAPAN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 63 JAPAN ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 64 JAPAN NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 65 JAPAN INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 66 JAPAN INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 67 JAPAN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 68 JAPAN NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 69 JAPAN ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 70 JAPAN ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 71 JAPAN BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 72 JAPAN BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 73 SOUTH KOREA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 74 SOUTH KOREA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 75 SOUTH KOREA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 76 SOUTH KOREA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 77 SOUTH KOREA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 78 SOUTH KOREA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 79 SOUTH KOREA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 80 SOUTH KOREA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 81 SOUTH KOREA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 82 SOUTH KOREA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 83 SOUTH KOREA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 84 SOUTH KOREA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 85 INDIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 86 INDIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 87 INDIA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 88 INDIA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 89 INDIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 90 INDIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 91 INDIA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 92 INDIA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 93 INDIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 94 INDIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 95 INDIA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 96 INDIA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 97 SINGAPORE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 98 SINGAPORE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 99 SINGAPORE ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 100 SINGAPORE NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 101 SINGAPORE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 102 SINGAPORE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 103 SINGAPORE BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 104 SINGAPORE NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 105 SINGAPORE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 106 SINGAPORE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 107 SINGAPORE BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 108 SINGAPORE BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 109 AUSTRALIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 110 AUSTRALIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 111 AUSTRALIA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 112 AUSTRALIA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 113 AUSTRALIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 114 AUSTRALIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 115 AUSTRALIA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 116 AUSTRALIA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 117 AUSTRALIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 118 AUSTRALIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 119 AUSTRALIA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 120 AUSTRALIA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 121 THAILAND BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 122 THAILAND BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 123 THAILAND ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 124 THAILAND NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 125 THAILAND INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 126 THAILAND INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 127 THAILAND BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 128 THAILAND NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 129 THAILAND ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 130 THAILAND ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 131 THAILAND BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 132 THAILAND BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 133 MALAYSIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 134 MALAYSIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 135 MALAYSIA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 136 MALAYSIA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 137 MALAYSIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 138 MALAYSIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 139 MALAYSIA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 140 MALAYSIA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 141 MALAYSIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 142 MALAYSIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 143 MALAYSIA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 144 MALAYSIA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 145 INDONESIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 146 INDONESIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 147 INDONESIA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 148 INDONESIA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 149 INDONESIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 150 INDONESIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 151 INDONESIA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 152 INDONESIA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 153 INDONESIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 154 INDONESIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 155 INDONESIA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 156 INDONESIA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 157 PHILIPPINES BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 158 PHILIPPINES BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
Table 159 PHILIPPINES ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 160 PHILIPPINES NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION)
Table 161 PHILIPPINES INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION)
Table 162 PHILIPPINES INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION)
Table 163 PHILIPPINES BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 164 PHILIPPINES NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION)
Table 165 PHILIPPINES ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION)
Table 166 PHILIPPINES ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION)
Table 167 PHILIPPINES BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION)
Table 168 PHILIPPINES BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION)
Table 169 REST OF ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION)
LIST OF FIGURES
Figure 1 ASIA-PACIFIC BLOOD SCREENING MARKET: SEGMENTATION
Figure 2 ASIA-PACIFIC BLOOD SCREENING MARKET: DATA TRIANGULATION
Figure 3 ASIA-PACIFIC BLOOD SCREENING MARKET: DROC ANALYSIS
Figure 4 ASIA-PACIFIC BLOOD SCREENING MARKET:BOTTOM UP APPROACH
Figure 5 ASIA-PACIFIC BLOOD SCREENING MARKET:TOP DOWN APPROACH
Figure 6 ASIA-PACIFIC BLOOD SCREENING MARKET: INTERVIEW DEMOGRAPHICS
Figure 7 ASIA-PACIFIC BLOOD SCREENING MARKET: DBMR MARKET POSITION GRID
Figure 8 ASIA-PACIFIC BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID
Figure 9 ASIA-PACIFIC BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID
Figure 10 ASIA-PACIFIC BLOOD SCREENING MARKET: THE MARKET CHALLENGE MATRIX
Figure 11 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA-PACIFIC BLOOD SCREENING MARKET
Figure 12 ASIA-PACIFIC BLOOD SCREENING MARKET: SEGMENTATION
Figure 13 RISE IN DEMAND OF BLOOD DONATIONS AND BLOOD DONORS AS WELL AS RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS EXPECTED TO DRIVE THE MARKET FOR BLOOD SCREENING MARKET IN THE FORECAST PERIOD 2018 TO 2025
Figure 14 REAGENTS & KITS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE BLOOD SCREENING MARKET IN 2018 & 2025
Figure 15 ASIA PACIFIC IS THE MAXIMUM GROWING AND MOST PROFITable REVENUE POCKETS FOR BLOOD SCREENING MARKET IN THE FORECAST PERIOD FROM 2018 TO 2025
Figure 16 ASIA-PACIFIC BLOOD SCREENING MARKET: BY PRODUCTS & SERVICES, 2017
Figure 17 ASIA-PACIFIC BLOOD SCREENING MARKET: BY TECHNOLOGY, 2017
Figure 18 ASIA-PACIFIC BLOOD SCREENING MARKET: BY DISEASE TYPE, 2017
Figure 19 ASIA-PACIFIC BLOOD SCREENING MARKET: BY END USER, 2017
Figure 20 ASIA-PACIFIC BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 21 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2017)
Figure 22 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025)
Figure 23 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2017 & 2025)
Figure 24 ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES (2018 TO 2025)
Figure 25 ASIA-PACIFIC BLOOD SCREENING MARKET MARKET: COMPANY SHARE 2017 (%)
Figure 1 ASIA-PACIFIC BLOOD SCREENING MARKET: SEGMENTATION
Figure 2 ASIA-PACIFIC BLOOD SCREENING MARKET: DATA TRIANGULATION
Figure 3 ASIA-PACIFIC BLOOD SCREENING MARKET: DROC ANALYSIS
Figure 4 ASIA-PACIFIC BLOOD SCREENING MARKET:BOTTOM UP APPROACH
Figure 5 ASIA-PACIFIC BLOOD SCREENING MARKET:TOP DOWN APPROACH
Figure 6 ASIA-PACIFIC BLOOD SCREENING MARKET: INTERVIEW DEMOGRAPHICS
Figure 7 ASIA-PACIFIC BLOOD SCREENING MARKET: DBMR MARKET POSITION GRID
Figure 8 ASIA-PACIFIC BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID
Figure 9 ASIA-PACIFIC BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID
Figure 10 ASIA-PACIFIC BLOOD SCREENING MARKET: THE MARKET CHALLENGE MATRIX
Figure 11 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF ASIA-PACIFIC BLOOD SCREENING MARKET
Figure 12 ASIA-PACIFIC BLOOD SCREENING MARKET: SEGMENTATION
Figure 13 RISE IN DEMAND OF BLOOD DONATIONS AND BLOOD DONORS AS WELL AS RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS EXPECTED TO DRIVE THE MARKET FOR BLOOD SCREENING MARKET IN THE FORECAST PERIOD 2018 TO 2025
Figure 14 REAGENTS & KITS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE BLOOD SCREENING MARKET IN 2018 & 2025
Figure 15 ASIA PACIFIC IS THE MAXIMUM GROWING AND MOST PROFITable REVENUE POCKETS FOR BLOOD SCREENING MARKET IN THE FORECAST PERIOD FROM 2018 TO 2025
Figure 16 ASIA-PACIFIC BLOOD SCREENING MARKET: BY PRODUCTS & SERVICES, 2017
Figure 17 ASIA-PACIFIC BLOOD SCREENING MARKET: BY TECHNOLOGY, 2017
Figure 18 ASIA-PACIFIC BLOOD SCREENING MARKET: BY DISEASE TYPE, 2017
Figure 19 ASIA-PACIFIC BLOOD SCREENING MARKET: BY END USER, 2017
Figure 20 ASIA-PACIFIC BLOOD SCREENING MARKET SNAPSHOT (2017)
Figure 21 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2017)
Figure 22 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025)
Figure 23 ASIA-PACIFIC BLOOD SCREENING MARKET: BY COUNTRY (2017 & 2025)
Figure 24 ASIA-PACIFIC BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES (2018 TO 2025)
Figure 25 ASIA-PACIFIC BLOOD SCREENING MARKET MARKET: COMPANY SHARE 2017 (%)
